246 related articles for article (PubMed ID: 12535262)
1. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.
Minari A; Husni R; Avery RK; Longworth DL; DeCamp M; Bertin M; Schilz R; Smedira N; Haug MT; Mehta A; Gordon SM
Transpl Infect Dis; 2002 Dec; 4(4):195-200. PubMed ID: 12535262
[TBL] [Abstract][Full Text] [Related]
2. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients.
Helmi M; Love RB; Welter D; Cornwell RD; Meyer KC
Chest; 2003 Mar; 123(3):800-8. PubMed ID: 12628881
[TBL] [Abstract][Full Text] [Related]
3. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.
Mohammad RA; Klein KC
Ann Pharmacother; 2006 Dec; 40(12):2148-54. PubMed ID: 17148653
[TBL] [Abstract][Full Text] [Related]
4. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients.
Patterson JE; Peters J; Calhoon JH; Levine S; Anzueto A; Al-Abdely H; Sanchez R; Patterson TF; Rech M; Jorgensen JH; Rinaldi MG; Sako E; Johnson S; Speeg V; Halff GA; Trinkle JK
Transpl Infect Dis; 2000 Mar; 2(1):22-8. PubMed ID: 11429006
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients.
Husni RN; Gordon SM; Longworth DL; Arroliga A; Stillwell PC; Avery RK; Maurer JR; Mehta A; Kirby T
Clin Infect Dis; 1998 Mar; 26(3):753-5. PubMed ID: 9524855
[TBL] [Abstract][Full Text] [Related]
6. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Mattner F; Chaberny IF; Weissbrodt H; Fischer S; Gastmeier P; Haubitz B; Gottlieb J; Mattner L; Strueber M
Mycoses; 2005; 48 Suppl 1():51-5. PubMed ID: 15826288
[TBL] [Abstract][Full Text] [Related]
7. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
8. Fungal infections in solid organ transplantation.
Silveira FP; Husain S
Med Mycol; 2007 Jun; 45(4):305-20. PubMed ID: 17510855
[TBL] [Abstract][Full Text] [Related]
9. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management.
Singh N; Husain S
J Heart Lung Transplant; 2003 Mar; 22(3):258-66. PubMed ID: 12633692
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
[TBL] [Abstract][Full Text] [Related]
11. Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies.
Gordon SM; Avery RK
Transpl Infect Dis; 2001 Sep; 3(3):161-7. PubMed ID: 11493398
[TBL] [Abstract][Full Text] [Related]
12. Aspergillus and lung transplantation.
Yeldandi V; Laghi F; McCabe MA; Larson R; O'Keefe P; Husain A; Montoya A; Garrity ER
J Heart Lung Transplant; 1995; 14(5):883-90. PubMed ID: 8800724
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study.
Gavalda J; Len O; San Juan R; Aguado JM; Fortun J; Lumbreras C; Moreno A; Munoz P; Blanes M; Ramos A; Rufi G; Gurgui M; Torre-Cisneros J; Montejo M; Cuenca-Estrella M; Rodriguez-Tudela JL; Pahissa A;
Clin Infect Dis; 2005 Jul; 41(1):52-9. PubMed ID: 15937763
[TBL] [Abstract][Full Text] [Related]
14. Voriconazole prophylaxis in lung transplant recipients.
Husain S; Paterson DL; Studer S; Pilewski J; Crespo M; Zaldonis D; Shutt K; Pakstis DL; Zeevi A; Johnson B; Kwak EJ; McCurry KR
Am J Transplant; 2006 Dec; 6(12):3008-16. PubMed ID: 17062003
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.
Solé A
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S161-5. PubMed ID: 19013342
[TBL] [Abstract][Full Text] [Related]
16. Aspergillus pneumonia in renal transplant recipients.
Zhang XD; Hu XP; Yin H; Wang W; Zhang X; Ma LL; Wang Y
Chin Med J (Engl); 2008 May; 121(9):791-4. PubMed ID: 18701042
[TBL] [Abstract][Full Text] [Related]
17. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.
Oren I; Haddad N; Finkelstein R; Rowe JM
Am J Hematol; 2001 Apr; 66(4):257-62. PubMed ID: 11279636
[TBL] [Abstract][Full Text] [Related]
18. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.
Morgan J; Wannemuehler KA; Marr KA; Hadley S; Kontoyiannis DP; Walsh TJ; Fridkin SK; Pappas PG; Warnock DW
Med Mycol; 2005 May; 43 Suppl 1():S49-58. PubMed ID: 16110792
[TBL] [Abstract][Full Text] [Related]
19. Aspergillus infections in lung transplant recipients: risk factors and outcome.
Solé A; Morant P; Salavert M; Pemán J; Morales P;
Clin Microbiol Infect; 2005 May; 11(5):359-65. PubMed ID: 15819861
[TBL] [Abstract][Full Text] [Related]
20. A survey of anti-fungal management in lung transplantation.
Dummer JS; Lazariashvilli N; Barnes J; Ninan M; Milstone AP
J Heart Lung Transplant; 2004 Dec; 23(12):1376-81. PubMed ID: 15607667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
